Back to top

Enigma Biomedical Group and Invicro Sign a Collaboration Agreement

August 28, 2018
No votes yet


Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug development, to work together on multiple projects, initially focusing on the enhancement of Invicro’s Amyloid IQ and Tau IQ platforms.